Acutaas margin drops 12.61 points sequentially as stock falls 5.99%
Year-on-year growth remained strong, but revenue fell faster than expenses sequentially, reversing four quarters of margin expansion.
Filed 24 Jul 2026, 12:32 IST · Acutaas Chemicals Ltd (ACUTAAS)
Key takeaways
- Consolidated net profit fell 44.15% QoQ as revenue declined 23.82% while expenses fell only 13.10%.
- Operating margin improved 9.74 percentage points YoY because revenue growth of 59.08% outpaced expense growth of 38.55%.
- The stock fell 5.77% on results day, reversing the usual pattern in which it rose after 7 of its last 8 results.
Price around the results
Q1FY27 reverses the Q4FY26 profit peak
Acutaas Chemicals reported consolidated net profit growth of 70.39% YoY, but profit fell 44.15% QoQ after the previous quarter's higher revenue base. The YoY improvement came from revenue growth of 59.08% and operating-profit growth of 122.10%, while the sequential decline reflected a 23.82% fall in revenue. Other income contributed only 1.73% of pre-tax profit, so the quarter's earnings were not materially supported by non-operating income.
Sequential margin compression came from weaker operating leverage
Operating margin narrowed 8.11 percentage points QoQ because expenses declined 13.10%, much less than the 23.82% drop in revenue. YoY, the reverse held: revenue grew 59.08% against expense growth of 38.55%, lifting margin by 9.74 percentage points. The tax rate also rose 3.61 percentage points YoY and 0.89 percentage points QoQ, limiting the conversion of pre-tax profit into net profit.
Margin remains above healthcare peers despite the first decline in five quarters
The 34.3% operating margin was 6.83 percentage points above the 27.47% median for the 13 Healthcare peers that had reported the same quarter. The margin had risen from 24.56% in Q1FY26 to 42.41% in Q4FY26, making Q1FY27 the first decline after four consecutive quarterly increases. The current level therefore remains sector-leading in the reported peer set, but is well below the recent Q4FY26 peak.
Certification adds a business-quality signal
The investor presentation said the company had received Responsible Care certification from the Indian Chemical Council. This adds a compliance and operating-standard milestone to a quarter in which earnings growth was driven mainly by operating performance rather than other income.
The market reaction was unusually negative for this stock
The stock fell 5.77% on the results-day session, including a 3.73% opening gap lower, with volume at 3.07 times the reference level. That direction was unusual: 7 of the last 8 results reactions were positive, and the median absolute move was 4.56%, making this decline both contrary to the recent pattern and larger than the typical move.
Q1FY27 at a glance
Consolidated figures as filed with NSE — cross-checked against an independent source.
| Line item | Q1FY27 | Q4FY26 | QoQ | YoY |
|---|---|---|---|---|
| Revenue | ₹330 cr | ₹433 cr | -23.82% | +59.08% |
| Other income | ₹2 cr | ₹11 cr | -83.80% | -88.71% |
| Expenses | ₹217 cr | ₹249 cr | -13.10% | +38.55% |
| Operating profit | ₹113 cr | ₹184 cr | -38.38% | +122.10% |
| Operating margin (%) | 34.30% | 42.41% | — | — |
| Interest | ₹1 cr | ₹1 cr | -4.20% | +78.12% |
| Depreciation | ₹10 cr | ₹10 cr | +1.97% | +20.79% |
| Profit before tax | ₹104 cr | ₹184 cr | -43.47% | +78.91% |
| Tax | ₹29 cr | ₹50 cr | -41.60% | +105.54% |
| Net profit | ₹75 cr | ₹134 cr | -44.15% | +70.39% |
| EPS (₹) | ₹9.07 | ₹16.09 | -43.63% | +67.65% |
Operating margin of 34.30% compares with a Healthcare sector median of 27.47% across 13 peers that have reported Q1FY27.
How the stock reacted
| Window | Stock | vs NIFTY |
|---|---|---|
| Results day | -5.77% | -5.34% |
| Next session | -2.64% | — |
Volume on the results session was 3.07× its 20-day average.
What management said
From the company’s own investor presentation. Each point is checked against the source document before it appears here.
New initiatives
- The company received Responsible Care certification from the Indian Chemical Council.
What to watch
- Whether revenue recovers from the Rs 329.67 cr base after the 23.82% QoQ decline.
- Whether operating margin stabilises above 34.3% after the 8.11 percentage-point sequential fall.
- Whether expenses continue to grow below revenue growth of 59.08% on a YoY basis.